New Purdue bankruptcy deal cuts out Sacklers’ legal immunity
By 
Sarah Houlton2025-01-29T13:56:00
$7.4 billion proposal will fund support for victims of US opioid crisis
Fifteen US states have reached a $7.4 billion (£6 billion) settlement-in-principle with Purdue Pharma and the Sackler family who own it. It looks to replace the 2021 settlement rejected by the US Supreme Court in June 2024 on grounds it broke bankruptcy law by giving the Sacklers blanket immunity from civil lawsuits, despite the fact that it was the company, not the Sacklers, filing for bankruptcy. The new settlement includes no automatic immunity for the Sacklers.